Skip to main navigation Skip to search Skip to main content

Efficacy and safety of phospholipid nanoparticles (VBI-S) in reversing intractable hypotension in patients with septic shock: a multicentre, open-label, repeated measures, phase 2a clinical pilot trial

  • Cuthbert Simpkins
  • , Michael Moncure
  • , Heather Klepacz
  • , Kristopher Roach
  • , Sadia Benzaquen
  • , Luis Diaz-Caballero
  • , Jonathan Cohen
  • , Daniel Haase
  • , Mukesh Kumar
  • , Harven DeShield
  • , Anthony Manasia
  • , Juan Rodriguez
  • , Prashanth Anamthathmakula
  • , Nik Hurt
  • , Bhaswati Mukherjee
  • , Krishna Talluri

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number102430
JournaleClinicalMedicine
Volume68
DOIs
StatePublished - Feb 2024
Externally publishedYes

ASJC Scopus Subject Areas

  • General Medicine

Keywords

  • Hypotension
  • Multiple organ dysfunction syndrome
  • Nitric oxide
  • Phospholipid nanoparticles
  • Sepsis

Cite this